Hofseth International AS ("HI"), a close associate of Hofseth Biocare ASA's (the
"Company") board member Roger Hofseth, has notified the Company that HI has made
the following purchases of shares in the Company.
On 11 May 2022, HI purchased 24,000 shares in the Company at an average price of
approximately NOK 3,89 for a total subscription amount of NOK 93,434.4.
On 29 December 2022, HI purchased 53,572 shares in the Company at an average
price of approximately NOK 2,80 for a total subscription amount of NOK
150,429.44.
On 30 December 2022, HI purchased 178,215 shares in the Company at an average
price of approximately NOK 3,36 for a total subscription amount of NOK
599,530.72.
Please see the attached notification forms for further information.
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements in the Market Abuse
Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading
Act section 5-12.